p16^INK4a and laminin-5γ2 chain expression during the progression of cervical neoplasia

References

• zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999; 111: 581–7
   PubMedGoogle Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796–802
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–9
   PubMed Web of Science ®Google Scholar
• Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246–50
   PubMed Web of Science ®Google Scholar
• Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, et al. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep 2003; 10: 175–9
   PubMed Web of Science ®Google Scholar
• Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001; 357: 1490–3
   PubMed Web of Science ®Google Scholar
• Herbert A, Singh N, Smith JA. Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: A 12-year study in Southampton and South-west Hampshire. Cytopathology 2001; 12: 26–36
   PubMedGoogle Scholar
• Tenti P, Romagnoli S, Silini E, Zappatore R, Spinillo A, Giunta P, et al. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol 1996; 106: 52–6
   Google Scholar
• Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536–45
   PubMed Web of Science ®Google Scholar
• Ryan MC, Tizard R, VanDevanter DR, Carter WG. Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 1994; 269: 22779–87
   PubMed Web of Science ®Google Scholar
• Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 1998; 185: 44–52
   PubMed Web of Science ®Google Scholar
• Soini Y, Maatta M, Salo S, Tryggvason K, Autio-Harmainen H. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol 1996; 180: 290–4
   Google Scholar
• Hao J, Yang Y, McDaniel KM, Dalkin BL, Cress AE, Nagle RB. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol 1996; 149: 1341–9
   Google Scholar
• Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 4132–9
   PubMed Web of Science ®Google Scholar
• Kohlberger P, Beneder C, Horvat R, Leodolter S, Breitenecker G. Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 2003; 89: 391–4
   Google Scholar
• Nordstrom B, Einhorn N, Silfversward C, Sjovall K, Tryggvason K, Auer G. Laminin-5 gamma 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract. Int J Gynecol Cancer 2002; 12: 105–9
   Google Scholar
• Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999; 91: 1882–7
   PubMed Web of Science ®Google Scholar
• Hellman K, Hellstrom AC, Silfversward C, Salo S, Aspenblad U, Nilsson B, et al. Cancer of the vagina: Laminin-5gamma2 chain expression and prognosis. Int J Gynecol Cancer 2000; 10: 391–6
   Google Scholar
• Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276–84
   PubMed Web of Science ®Google Scholar
• Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998; 48: 580–5
   PubMed Web of Science ®Google Scholar
• Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741–8
   PubMed Web of Science ®Google Scholar
• Salo S, Haakana H, Kontusaari S, Hujanen E, Kallunki T, Tryggvason K. Laminin-5 promotes adhesion and migration of epithelial cells: Identification of a migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice. Matrix Biol 1999; 18: 197–210
   PubMed Web of Science ®Google Scholar
• Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004; 10: 2407–14
   PubMed Web of Science ®Google Scholar
• Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002; 52: 375–83
   PubMed Web of Science ®Google Scholar
• Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747–53
   PubMed Web of Science ®Google Scholar
• Lindstrom MS, Klangby U, Inoue R, Pisa P, Wiman KG, Asker CE. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. Exp Cell Res 2000; 256: 400–10
   PubMed Web of Science ®Google Scholar
• Herbsleb M, Knudsen UB, Orntoft TF, Bichel P, Norrild B, Knudsen A, et al. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia. Apmis 2001; 109: 607–17
   PubMed Web of Science ®Google Scholar
• Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633–8
   PubMed Web of Science ®Google Scholar
• von Knebel Doeberitz M. New molecular tools for efficient screening of cervical cancer. Dis Markers 2001; 17: 123–8
   PubMed Web of Science ®Google Scholar
• Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 2004; 23: 7441–7
   PubMed Web of Science ®Google Scholar
• Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus–related cervical neoplasia. Am J Surg Pathol 2001; 25: 884–91
   PubMed Web of Science ®Google Scholar
• Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, et al. Genetic alterations in cervical carcinomas: Frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002; 101: 427–33
   PubMed Web of Science ®Google Scholar
• Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B, Auer G. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions. Mod Pathol 2001; 14: 279–84
   Google Scholar
• Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 1999; 81: 1071–9
   PubMedGoogle Scholar
• Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: An immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999; 34: 305–9
   PubMed Web of Science ®Google Scholar
• Hindermann W, Berndt A, Haas KM, Wunderlich H, Katenkamp D, Kosmehl H. Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis. Cancer Detect Prev 2003; 27: 109–15
   Google Scholar
• Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H, Hirohashi S. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 2001; 91: 1129–41
   Google Scholar
• Andersson S, Hellström A-C, Ångström T, Stendahl U, Auer G, Wallin K-L. The Clinicopathological significance of laminin-5 gamma 2 chain expression in cervical squamous- and adenocarcinoma. 2005 (in press).
   Google Scholar
• Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest 1999; 79: 1137–43
   PubMed Web of Science ®Google Scholar
• Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003; 163: 477–91
   PubMed Web of Science ®Google Scholar
• Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995; 85: 202–10
   PubMed Web of Science ®Google Scholar
• Reid REA. Preinvasive disease. Practical gynecologic oncology2nd ed, J Berek, NF Hacker. Williams & Wilkins, Baltimore 1994
   Google Scholar
• Nordemar S, Kronenwett U, Auer G, Hogmo A, Lindholm J, Edstrom S, et al. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res 2001; 21: 509–12
   Google Scholar